Given the substantiation that the adenosine A2AR and CD73 take part in the etiology of epilepsy in both clinical and rodent experiments, we designed this study to investigate changes between epilepsy cases and control individuals and from genetic variations aspects which are worth exploring as therapeutic targets for treatment development. This evidence concerns the gene NT5E and epilepsy.